Nail Pigmentation in the Acquired Immunodeficiency Syndrome (AIDS)
Authors: ANAND P. PANWALKER
Journal: Annals of Internal Medicine (1987)

Letters and Corrections1 December 1987Nail Pigmentation in the Acquired Immunodeficiency Syndrome (AIDS)ANAND P. PANWALKER, M.D.ANAND P. PANWALKER, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-107-6-943_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Furth and Kazakis (1) reported two black patients with the acquired immunodeficiency syndrome (AIDS) who developed progressive nail pigmentation after therapy with azidothymidine (now zidovudine; Retrovir, Burroughs Wellcome Company, Research Triangle Park, North Carolina). I have also noted bluish discoloration of the nails in two black patients with AIDS. However, in the first patient, a 44-year-old black man, the finger and toenail discoloration preceded azidothymidine therapy by 6 months. During these 6 months the patient had received oral trimethoprim-sulfamethoxazole and nystatin solution. The nails appeared "cyanotic" and the pigmentation has persisted after 8 months of azidothymidine therapy....Reference1. FURTHKAZAKIS PA. Nail pigmentation changes associated with azidothymidine (zidovudine). Ann Intern Med. 1987;107:350. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Thomas Jefferson University Wilmington, DE 19805 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByHIV and the SkinHIV and the SkinAn Update on Drug-Induced PigmentationThe Nail in Systemic DiseaseDrug-induced Nail DisordersNail Reactions to Antibiotics, Antimalarials, and Other MedicationsToxicidad cutánea de los fármacos antirretroviralesNail abnormalities associated with systemic pathologiesThe Nail in Systemic DiseaseDrug-induced Nail ChangesInvestigation of emtricitabine-associated skin pigmentation and safety in HIV-1-infected Japanese patientsMelanonychia in Patients Infected with Human Immunodeficiency Virus Original CommunicationCutaneous toxicities of antiretroviral therapy for HIVDisorders of NailsReacciones cutáneas adversas a fármacos en los pacientes con infección por el VIH en la era TARGACutaneous Drug Reactions in HIV-Infected Patients in the HAART EraPrévalence des manifestations dermatologiques chez les malades infectés par le VIH au Sénégal et association avec le degré d'immunodépressionDiagnosis and management of nail pigmentationsDyschromonychia: clinical significance in a South African populationNail Pigmentation and Fatigue in a 39‐Year‐Old WomanCutaneous manifestations of antiretroviral therapySKIN LESIONS IN HIV-POSITIVE AND HIV-NEGATIVE PATIENTS IN SOUTH INDIAMelasma and acquired immunodeficiency syndrome (AIDS)DISORDERS OF THE NAILS AND HAIR ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTIONCUTANEOUS HYPERPIGMENTATION CAUSED BY SYSTEMIC DRUGSAcral hyperpigmented macules and longitudinal melanonychia in AIDS patientsNail Pigmentation Associated with Zidovudine: A Review and Report of a CaseLongitudinal Pigmented Nail BandsAntiretroviral therapyPigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with zidovudineNail and mucocutaneous hyperpigmentation with azidothymidine therapyNail Dyschromia Associated with ZidovudinePhilip C. Don, MD, PhD, Francesca Fusco, MD, Philip Fried, MD, Amy Batterman, MD, Frederick P. Duncanson, MD, Theodore H. Lenox, MD, Natalie C. Klein, MDDevelopment of nail pigmentation during zidovudine therapyCutaneous manifestations of aids in adults and infantsNail discoloration and human immunodeficiency virus infectionMiscellaneous antibacterial and antiviral drugsNail Pigmentation Associated with Zidovudine 1 December 1987Volume 107, Issue 6Page: 943-944KeywordsAIDSAzidothymidineNystatin Issue Published: 1 December 1987 PDF DownloadLoading ...